6.190USD+2.15%Mkt Cap: 105.05M USDP/E: —Last update: 2026-05-26
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap105.05M USD
Enterprise Value82.20M USD
Revenue (TTM)37.16M USD
Gross Profit32.14M USD
Net Income (TTM)-17.89M USD
Revenue/Share2.731 USD
Last Price6.190 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS92511W1080
Valuation
P/E (Trailing)—
P/E (Forward)-4.13
PEG—
EV/EBITDA-6.29
EV/Revenue2.21
P/S2.73
P/B4.10
EPS (TTM)-1.10
EPS (Forward)-1.43
52W Range
3.28044% of range9.821
52W High9.821 USD
52W Low3.280 USD
Profitability
Gross Margin90.33%
Oper. Margin-193.41%
EBITDA Margin-35.14%
Profit Margin-50.27%
ROE-72.29%
ROA-37.95%
Growth
Revenue Growth46.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.63M USD
CapEx (TTM)—
FCF Margin-32.72%
FCF Yield-11.58%
Net Debt-19.16M USD
Net Debt/EBITDA1.47
Balance Sheet
Debt/Equity0.07
Current Ratio2.10
Quick Ratio1.75
Book Value/Sh1.440 USD
Cash/Share1.199 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 25, 2025
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)16.43 USD
Target Range10.00 USD – 20.00 USD
# Analysts4
Ownership
Shares Out.17.18M
Float7.90M
Insiders48.69%
Institutions27.87%
Short Interest
Short Ratio7.0d
Short % Float6.59%
Short % Out.3.39%
Shares Short582.21K
Short (prev mo.)497.75K
Technical
SMA 506.114 (+1.2%)
SMA 2005.913 (+4.7%)
Beta1.55
S&P 52W Chg28.31%
Avg Vol (30d)88.66K
Avg Vol (10d)76.94K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—